News from Foundation Venture Capital Group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 12, 2017, 13:25 ET Actinobac Biomed, Inc., Receives Investment To Advance Promising Treatment for Blood Cancers

Actinobac Biomed Inc., started with an investment from Foundation Venture Capital Group (FVCG), Inc., an affiliate of New Jersey Health Foundation...


Dec 06, 2016, 13:50 ET Visikol Inc. Launches Visikol® HISTO™ Platform for 3D Histology With Easy to Use Starter Kit

Visikol Inc., originally funded with an investment from Foundation Venture Capital Group, has launched Visikol® HISTO™, the market's first...


Jul 07, 2016, 12:10 ET Visikol Receives $225,000 from the National Science Foundation To Improve Skeletal Visualization Technology for Developmental & Reproductive Toxicology Studies

Visikol Inc., originally funded with an investment from Foundation Venture Capital Group Inc., has received a $225,000 Small Business Innovation...


Oct 14, 2014, 11:40 ET Actinobac Biomed Receives $905,000 Small Business Grant from NCI to Advance Blood Cancer Research

Actinobac Biomed Inc., has received a $905,040 Small Business Technology Transfer Grant (STTR) Phase II Award from the National Institutes of...


Jan 31, 2014, 11:20 ET Foundation Venture Capital Group portfolio company, Snowdon, issued patents to treat pain and advance drug discovery

Drug discovery and development company Snowdon Inc., a Foundation Venture Capital Group portfolio company, has been issued two new patents to treat...


Nov 07, 2013, 11:25 ET Actinobac Biomed Founder Receives Two Awards For Promising New Drug

 Scott Kachlany, PhD, founder of Actinobac Biomed, Inc., has received a Thomas Edison Patent of the Year Award from the Research and...


Oct 28, 2013, 11:35 ET Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor

 Researchers from GeneAssess, Inc., a Foundation Venture Capital Group portfolio company, announce the publication of the genetic studies that...


Oct 03, 2013, 13:35 ET The Michael J. Fox Foundation Funds Research to Develop Parkinson's Blood Test

 Research being performed by Durin Technologies, Inc., exploring the development of a novel blood test for Parkinson's disease was recently...


Apr 18, 2013, 13:20 ET Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair

 Newly formed NovoPedics, Inc., has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its...